We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JRN
201
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $1.5M | 0.14% |
131,499
-160,725
| -55% | -$1.56M |
|
202
Citi Trends
CTRN
$524M
| $1.49M | 0.14% |
59,170
+8,852
| +18% | +$202K |
|
|
I
203
DELISTED
INTELSAT S. A.
I
| $1.49M | 0.14% |
85,834
+73,170
| +578% | +$1.26M |
|
|
ENZ
204
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.49M | 0.14% |
335,090
-50,878
| -13% | -$243K |
|
205
Quad
QUAD
$430M
| $1.49M | 0.14% |
64,765
+41,761
| +182% | +$882K |
|
|
TBI
206
Trueblue
TBI
$234M
| $1.48M | 0.14% |
66,474
+5,312
| +9% | +$126K |
|
207
Entravision Communication
EVC
$983M
| $1.48M | 0.14% |
227,632
-150,099
| -40% | -$844K |
|
|
SHOS
208
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
| $1.47M | 0.14% |
111,808
+59,688
| +115% | +$826K |
|
209
BlackRock Enhanced International Dividend Trust
BGY
$512M
| $1.47M | 0.14% |
+217,491
| New | +$1.55M |
|
|
AAIC
210
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.47M | 0.14% |
+55,053
| New | +$1.49M |
|
211
Inogen
INGN
$167M
| $1.46M | 0.14% |
46,669
+34,383
| +280% | +$833K |
|
|
ETV
212
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
| $1.46M | 0.14% |
+104,069
| New | +$1.54M |
|
|
EMWP
213
DELISTED
Eros Media World PLC
EMWP
| $1.46M | 0.14% |
3,456
-2,017
| -37% | -$767K |
|
214
Qualys
QLYS
$4.84B
| $1.44M | 0.14% |
38,171
+6,681
| +21% | +$223K |
|
215
Red Robin
RRGB
$134M
| $1.44M | 0.14% |
+18,651
| New | +$1.18M |
|
216
Astronics
ATRO
$3.45B
| $1.43M | 0.14% |
47,305
-59,137
| -56% | -$1.56M |
|
217
MarineMax
HZO
$800M
| $1.43M | 0.14% |
71,377
-1,171
| -2% | -$21.5K |
|
|
SWZ
218
Swiss Helvetia Fund
SWZ
$76.3M
| $1.43M | 0.14% |
+128,262
| New | +$1.66M |
|
|
PDLI
219
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.43M | 0.14% |
185,225
+122,196
| +194% | +$967K |
|
220
Cohu
COHU
$2.39B
| $1.43M | 0.14% |
+119,830
| New | +$1.36M |
|
|
CUB
221
DELISTED
Cubic Corporation
CUB
| $1.42M | 0.14% |
+27,037
| New | +$1.33M |
|
|
BAS
222
DELISTED
Basis Energy Services, Inc.
BAS
| $1.42M | 0.14% |
+355
| New | +$2.24M |
|
|
PTLA
223
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.42M | 0.14% |
50,016
+38,784
| +345% | +$1.08M |
|
|
ACW
224
DELISTED
Accuride Corp
ACW
| $1.41M | 0.13% |
323,755
+117,272
| +57% | +$529K |
|
225
InterDigital
IDCC
$6.68B
| $1.4M | 0.13% |
+26,430
| New | +$1.27M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.